Human homeostasis

Global Blood Glucose Test Strips Market Report 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 30, 2021
Diabetes, Health, Medical devices, Diabetes, Branches of biology, Medicine, Articles, Blood tests, Blood sugar level, Human homeostasis, Glucose, Market analysis, Test strip, Etest, Blood glucose monitoring

The "Global Blood Glucose Test Strips Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Blood Glucose Test Strips Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • This study identifies the availability of products on online channels as one of the prime reasons driving the blood glucose test strips market growth during the next few years.
  • The report on blood glucose test strips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • Also, the blood glucose test strips market analysis report includes information on upcoming trends and challenges that will influence market growth.

CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms

Retrieved on: 
Thursday, June 10, 2021
Branches of biology, Autonomic nervous system, Baroreflex, Blood pressure, Cardiovascular physiology, Human homeostasis, Reflexes, Neuromodulation, Baroreceptor, Therapy

The novel ultrasound-guided technique is the latest advancement of CVRxs Barostim Baroreflex Activation Therapy (BAT) to treat the symptoms of HF patients.

Key Points: 
  • The novel ultrasound-guided technique is the latest advancement of CVRxs Barostim Baroreflex Activation Therapy (BAT) to treat the symptoms of HF patients.
  • Commenting on the technology, Dr. Allred said, This new approach to treatment represents a potentially game-changing advancement in the way we manage patients with HF symptoms.
  • We are excited to participate in this study evaluating the ultrasound-guided approach as a new implant technique to deliver this therapy.
  • CVRx is dedicated to improving patient outcomes, quality of life, and overall cardiovascular health via novel baroreceptor neuromodulation therapies.

Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey

Retrieved on: 
Tuesday, June 8, 2021
Medicine, Medical specialties, Clinical medicine, Diabetes, Blood tests, Blood sugar level, Human homeostasis, Blood glucose monitoring, Biosensor, Glucose, Monitoring, Diabetes management

As GBS is advancing to clinical trials of its saliva glucose biosensor, it conducted a global voice of customer survey of diabetes patients to verify the desirability, discuss the applications in daily life and review the product features of its Saliva Glucose Biosensor.

Key Points: 
  • As GBS is advancing to clinical trials of its saliva glucose biosensor, it conducted a global voice of customer survey of diabetes patients to verify the desirability, discuss the applications in daily life and review the product features of its Saliva Glucose Biosensor.
  • The comprehensive global survey featuring more than 300 patients worldwide living with diabetes revealed strong support for a non-invasive alternative to current Standards of Care (SOC) in glucose monitoring.
  • People living with diabetes need to feel confident and comfortable using a glucose monitoring device to help manage and supplement their medication administration.
  • Our Biosensor technology introduces the first exponential innovation in self glucose monitoring since 1971, enabling patients to monitor glucose in saliva, hence resulting in greater compliance with glucose monitoring and better glucose level control.

DGAP-News: APEIRON Biologics' APN01 selected for large-scale US trial in COVID-19

Retrieved on: 
Wednesday, May 19, 2021
Clinical research, Branches of biology, Medicine, Design of experiments, Clinical trials, Physiology, Human homeostasis, Raas, Placebo-controlled study, Renin, Placebo, ACTIV-4d RAAS trial, APN01 (alunacedase alfa), APEIRON Biologics AG, ACTIV-4D RAAS TRIAL, APN01 (ALUNACEDASE ALFA), APEIRON BIOLOGICS AG

The trial is largely funded by public grants.\nAPEIRON\'s recently completed Phase 2 trial showed significant improvement in certain parameters of the Renin Angiotensin Aldosterone System (RAAS) with APN01 treatment compared to placebo.

Key Points: 
  • The trial is largely funded by public grants.\nAPEIRON\'s recently completed Phase 2 trial showed significant improvement in certain parameters of the Renin Angiotensin Aldosterone System (RAAS) with APN01 treatment compared to placebo.
  • Data also suggested that APN01 will confer greatest therapeutic benefit to patients with lower WHO scores.
  • The randomized, double-blinded, placebo controlled ACTIV-4d RAAS trial will enroll approximately 1,600 hospitalized patients with COVID-19, at more than 50 individual sites.
  • APN01 will be one of at least three agents to be evaluated in the trial.\n"We are highly motivated and honored, that APN01 was selected for this government funded US program.

Rare Brain Damaged Patient May Settle Controversy Over Fish Pain

Retrieved on: 
Tuesday, April 27, 2021
Branches of biology, Nervous system, Pain, Cerebral cortex, Nociception, Homeostasis, Human homeostasis, Insular cortex, Affect

However, some researchers highlighted the fact that fish lack certain cortical regions (the ACC and the insula) associated with the emotional unpleasantness of pain or "pain affect".\nBut a brain damaged patient, "Roger", who had these regions of his brain destroyed by disease was examined and, surprisingly, his pain sensations, including the experience of the emotional unpleasantness of pain, were not only intact but were more sensitive than average.

Key Points: 
  • However, some researchers highlighted the fact that fish lack certain cortical regions (the ACC and the insula) associated with the emotional unpleasantness of pain or "pain affect".\nBut a brain damaged patient, "Roger", who had these regions of his brain destroyed by disease was examined and, surprisingly, his pain sensations, including the experience of the emotional unpleasantness of pain, were not only intact but were more sensitive than average.
  • The lead author of the new paper, Phil Halper, realized that Roger\'sand similar cases may represent a new empirical window into the world of animal pain.
  • The team examined anatomical damage detailed in multiple studies, including Roger\'s, and showed that no single cortical region seems to be necessary for pain affect.
  • This finding supports what Rudrauf calls "Neurofunctional Resilience", the idea that the brain can flexibly employ multiple different systems to ensure certain essential functions like pain affect.

Rare Brain Damaged Patient May Settle Controversy Over Fish Pain

Retrieved on: 
Tuesday, April 27, 2021
Branches of biology, Nervous system, Pain, Cerebral cortex, Nociception, Homeostasis, Human homeostasis, Insular cortex, Affect

However, some researchers highlighted the fact that fish lack certain cortical regions (the ACC and the insula) associated with the emotional unpleasantness of pain or "pain affect".\nBut a brain damaged patient, "Roger", who had these regions of his brain destroyed by disease was examined and, surprisingly, his pain sensations, including the experience of the emotional unpleasantness of pain, were not only intact but were more sensitive than average.

Key Points: 
  • However, some researchers highlighted the fact that fish lack certain cortical regions (the ACC and the insula) associated with the emotional unpleasantness of pain or "pain affect".\nBut a brain damaged patient, "Roger", who had these regions of his brain destroyed by disease was examined and, surprisingly, his pain sensations, including the experience of the emotional unpleasantness of pain, were not only intact but were more sensitive than average.
  • The lead author of the new paper, Phil Halper, realized that Roger\'sand similar cases may represent a new empirical window into the world of animal pain.
  • The team examined anatomical damage detailed in multiple studies, including Roger\'s, and showed that no single cortical region seems to be necessary for pain affect.
  • This finding supports what Rudrauf calls "Neurofunctional Resilience", the idea that the brain can flexibly employ multiple different systems to ensure certain essential functions like pain affect.

Blood Glucose Test Strips Market Research Report by Technology, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

Retrieved on: 
Monday, November 2, 2020
Diabetes, Health sciences, Health, Branches of biology, Blood sugar level, Human homeostasis, Pharmacy, Online pharmacy, Glucose, Draft:Bionime

Blood Glucose Test Strips Market Research Report by Technology (Channel Technology and Wicking Technology), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19

Key Points: 
  • Blood Glucose Test Strips Market Research Report by Technology (Channel Technology and Wicking Technology), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19
    This research report categorizes the Blood Glucose Test Strips to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Technology, the Blood Glucose Test Strips Market studied across Channel Technology and Wicking Technology.
  • Based on Distribution Channel, the Blood Glucose Test Strips Market studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Glucose Test Strips Market during the forecast period?
  • What are the modes and strategic moves considered suitable for entering the Global Blood Glucose Test Strips Market?

Trividia Health, Inc. Announces Launch of Test Buddy™ and Healthy Tracks for Pets™

Retrieved on: 
Tuesday, September 29, 2020
Medical devices, Health, Consumer, Diabetes, Pets, Veterinary, Clinical medicine, Branches of biology, Endocrine system, Diabetes, Blood tests, RTT, Blood sugar level, Human homeostasis, Blood lancet, Glucose, Insulin

The Test Buddy Pet-Monitoring Blood Glucose System is affordably priced and comes with 50 test strips and Healthy Tracks for Pets Lancing Device and lancets to conveniently monitor your dog or cats blood glucose.

Key Points: 
  • The Test Buddy Pet-Monitoring Blood Glucose System is affordably priced and comes with 50 test strips and Healthy Tracks for Pets Lancing Device and lancets to conveniently monitor your dog or cats blood glucose.
  • The Test Buddy Meter has Bluetooth capability that allows you to upload your pets results into the Test Buddy App, available on iOS and Android platforms.
  • The Test Buddy App also allows you track your pets glucose health and share results and trending information with your veterinarian.
  • In addition to the Test Buddy Pet-Monitoring Blood Glucose System, the launch of the Healthy Tracks for Pets Insulin Syringes will include U-40 and U-100 syringes in a variety of gauges and sizes.

Leading Medical Supplier Dr. Joint Care Now Carrying Freestyle Libre and Dr. Ho's Decompression Belt

Retrieved on: 
Tuesday, August 18, 2020
Diabetes, Blood sugar level, Human homeostasis

"At Dr. Joint Care, we're committed to serving our patients and improving their health.

Key Points: 
  • "At Dr. Joint Care, we're committed to serving our patients and improving their health.
  • By adding The FreeStyle Libre and DR-HO'S Back Relief Decompression Belt to our line of offerings, we can further these initiatives through advanced, easy-to-use technologies."
  • The FreeStyle Libre allows diabetic patients to monitor their blood glucose levels anywhere and anytime without the hassle of a finger stick.
  • The FreeStyle Libre and DR-HO'S Back Relief Decompression Belt provide safe, effective, and affordable care from the comfort of your home.

United States Blood Glucose Test Strips Market, 2015-2019 and 2027F

Retrieved on: 
Friday, July 31, 2020
Branches of biology, Clinical medicine, Blood tests, Endocrine system, Diabetes, Blood sugar level, Human homeostasis, Glucose, Insulin, Test strip, Glucose meter

The United States market for the blood glucose test strips is poised to register a healthy growth rate over the forecast period.

Key Points: 
  • The United States market for the blood glucose test strips is poised to register a healthy growth rate over the forecast period.
  • Thereport presents an in-depth assessment of the United States' blood glucose test strips market dynamics, opportunities, future roadmap, competitive outlook and discusses foremost trends.
  • The report gives the most up-to-date industry statistics at the real market place situation and future outlook in the United States blood glucose test strips market.
  • The report provides a clear insight into modern-day and future traits of the United States blood glucose test strips market.